Guardado en:
| Autores principales: | Sezgin Yeni, Hakan Kilicarslan, Gokhan Ocakoglu, Burhan Coskun, Mehmet Cagatay Cicek, Kadir Omur Gunseren, Ismet Yavascaoglu, Onur Kaygisiz |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.490 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Outcomes and considerations for retrograde intrarenal surgery (RIRS) in the setting of multiple and large renal stones (>15 mm) in children: Findings from multicentre and real‐world setting
por: Patrick Juliebø‐Jones, et al.
Publicado: (2024)
por: Patrick Juliebø‐Jones, et al.
Publicado: (2024)
Does instrumentation and irrigation configuration affect intrarenal pressure during PCNL?
por: Evan Seibly, et al.
Publicado: (2026)
por: Evan Seibly, et al.
Publicado: (2026)
Cost‐effectiveness of Resonance® metallic ureteral stent compared with standard polyurethane ureteral stents in malignant ureteric obstruction: A cost‐utility analysis
por: Dawn M. Cooper, et al.
Publicado: (2024)
por: Dawn M. Cooper, et al.
Publicado: (2024)
Long‐term outcomes of cutaneous ureterostomy with the aim of stent‐free stoma
por: Chul Jang Kim, et al.
Publicado: (2025)
por: Chul Jang Kim, et al.
Publicado: (2025)
Patient experience of bladder cancer: A data linkage study
por: Snehadhar Shah, et al.
Publicado: (2024)
por: Snehadhar Shah, et al.
Publicado: (2024)
Health utility value of overactive bladder in Japanese older adults
por: Takashi Yoshioka, et al.
Publicado: (2024)
por: Takashi Yoshioka, et al.
Publicado: (2024)
Outcomes of Aquablation in BPH with bladder stones: Analysis of the ICARUS database
por: Joshua D. Cabral, et al.
Publicado: (2026)
por: Joshua D. Cabral, et al.
Publicado: (2026)
The allium stent for the complex ureteral stricture‐deeper experience of a series case review
por: Hanqi Lei, et al.
Publicado: (2025)
por: Hanqi Lei, et al.
Publicado: (2025)
Ureteral stent symptoms: A systematic review and meta‐analysis comparing the use of mirabegron and tamsulosin
por: Daniel Madarshahian, et al.
Publicado: (2025)
por: Daniel Madarshahian, et al.
Publicado: (2025)
Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
por: Alison Hiong, et al.
Publicado: (2025)
por: Alison Hiong, et al.
Publicado: (2025)
Acu‐URO17 is a highly sensitive and specific bladder cancer biomarker
por: Liwu Guo, et al.
Publicado: (2024)
por: Liwu Guo, et al.
Publicado: (2024)
Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
por: Hugo Klempfner, et al.
Publicado: (2024)
por: Hugo Klempfner, et al.
Publicado: (2024)
Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
por: Serdar Turan, et al.
Publicado: (2025)
por: Serdar Turan, et al.
Publicado: (2025)
Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
por: Katherina Y. Chen, et al.
Publicado: (2026)
por: Katherina Y. Chen, et al.
Publicado: (2026)
Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
por: Yin Zhou, et al.
Publicado: (2024)
por: Yin Zhou, et al.
Publicado: (2024)
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
por: Liam Mannion, et al.
Publicado: (2024)
por: Liam Mannion, et al.
Publicado: (2024)
Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
por: Shugo Yajima, et al.
Publicado: (2025)
por: Shugo Yajima, et al.
Publicado: (2025)
Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer
por: Yu Ishizuya, et al.
Publicado: (2026)
por: Yu Ishizuya, et al.
Publicado: (2026)
Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
por: Kira Furlano, et al.
Publicado: (2024)
por: Kira Furlano, et al.
Publicado: (2024)
Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications
por: Rodolfo Hurle, et al.
Publicado: (2025)
por: Rodolfo Hurle, et al.
Publicado: (2025)
Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review
por: Sean Lim, et al.
Publicado: (2026)
por: Sean Lim, et al.
Publicado: (2026)
The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
por: Kunal K. Sindhu, et al.
Publicado: (2024)
por: Kunal K. Sindhu, et al.
Publicado: (2024)
Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer
por: Jacob Hanna, et al.
Publicado: (2026)
por: Jacob Hanna, et al.
Publicado: (2026)
Long non‐coding RNAs define favourable biology in high‐risk non‐muscle‐invasive bladder cancer
por: Rachel Weng, et al.
Publicado: (2025)
por: Rachel Weng, et al.
Publicado: (2025)
Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
por: Mohammed Al‐Zubaidi, et al.
Publicado: (2024)
por: Mohammed Al‐Zubaidi, et al.
Publicado: (2024)
Understanding oncological and sexual function outcomes with gynaecological organ preserving cystectomy in women with bladder cancer; a systematic review
por: Rebecca Martin, et al.
Publicado: (2025)
por: Rebecca Martin, et al.
Publicado: (2025)
Long‐term outcome of transurethral laser ablation for recurrent non‐muscle invasive bladder cancer: An EORTC risk‐matched study
por: Chase Peng Yun Ng, et al.
Publicado: (2025)
por: Chase Peng Yun Ng, et al.
Publicado: (2025)
Long‐term follow‐up of intradetrusor botulinum toxin utilisation: A comparison of patients with multiple sclerosis and idiopathic overactive bladder
por: William Chui, et al.
Publicado: (2024)
por: William Chui, et al.
Publicado: (2024)
A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
por: John Lahoud, et al.
Publicado: (2024)
por: John Lahoud, et al.
Publicado: (2024)
Real‐world use of maintenance bacillus Calmette‐Guérin therapy in patients with non‐muscle‐invasive bladder cancer in Japan: ASUKA study
por: Makito Miyake, et al.
Publicado: (2025)
por: Makito Miyake, et al.
Publicado: (2025)
Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
por: Amandeep Arora, et al.
Publicado: (2025)
por: Amandeep Arora, et al.
Publicado: (2025)
Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
por: Thomas Philip Cahill, et al.
Publicado: (2024)
por: Thomas Philip Cahill, et al.
Publicado: (2024)
Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer
por: Kylie Yen‐Yi Lim, et al.
Publicado: (2025)
por: Kylie Yen‐Yi Lim, et al.
Publicado: (2025)
Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
por: Cameron E. Alexander, et al.
Publicado: (2024)
por: Cameron E. Alexander, et al.
Publicado: (2024)
Unilateral J‐cut division versus partial and subtotal removal techniques in female patients with mesh‐related urethral obstruction: Multicentric comparative study
por: Bülent Çetinel, et al.
Publicado: (2024)
por: Bülent Çetinel, et al.
Publicado: (2024)
Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
por: Mathew Thakur, et al.
Publicado: (2024)
por: Mathew Thakur, et al.
Publicado: (2024)
Giant testicular germ‐cell tumours—An analysis of relative incidence and clinical features based on a clinical case series and a survey of the literature
por: Markus Angerer, et al.
Publicado: (2026)
por: Markus Angerer, et al.
Publicado: (2026)
Prognostic factors and treatment impact on overall survival in patients with renal neuroendocrine tumour
por: Olamide O. Omidele, et al.
Publicado: (2024)
por: Olamide O. Omidele, et al.
Publicado: (2024)
Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort
por: Goran Bencina, et al.
Publicado: (2024)
por: Goran Bencina, et al.
Publicado: (2024)
Ejemplares similares
-
Outcomes and considerations for retrograde intrarenal surgery (RIRS) in the setting of multiple and large renal stones (>15 mm) in children: Findings from multicentre and real‐world setting
por: Patrick Juliebø‐Jones, et al.
Publicado: (2024) -
Does instrumentation and irrigation configuration affect intrarenal pressure during PCNL?
por: Evan Seibly, et al.
Publicado: (2026) -
Cost‐effectiveness of Resonance® metallic ureteral stent compared with standard polyurethane ureteral stents in malignant ureteric obstruction: A cost‐utility analysis
por: Dawn M. Cooper, et al.
Publicado: (2024) -
Long‐term outcomes of cutaneous ureterostomy with the aim of stent‐free stoma
por: Chul Jang Kim, et al.
Publicado: (2025) -
Patient experience of bladder cancer: A data linkage study
por: Snehadhar Shah, et al.
Publicado: (2024)